13F-HR filed by Ikarian Capital, LLC
Ikarian Capital, LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 113 holding rows worth $574,070,830.
- Accession
- 0001420506-24-001556
- Filer
- CIK 1778253
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 130 entries on the cover page, a total value of $574,070,830 stated on the cover page (in dollars after the unit check, H1), rows summing to $574,070,830 with VALUE read as dollars as filed, 13F file number 028-19721. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 1,500 | $36,450,000 | dollars as filed | put |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 1,500 | $36,450,000 | dollars as filed | call |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 5,070 | $33,969,000 | dollars as filed | call |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 203,612 | $32,170,696 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 588,818 | $26,373,158 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 800,277 | $21,751,529 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 600 | $18,747,000 | dollars as filed | call |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 445,451 | $18,174,401 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 4,225 | $17,474,600 | dollars as filed | put |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,000 | $15,800,000 | dollars as filed | call |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 6,000 | $15,198,000 | dollars as filed | call |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 309,540 | $14,006,685 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 1,000 | $13,767,000 | dollars as filed | call |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 586,552 | $13,707,720 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 3,000 | $12,408,000 | dollars as filed | call |
| Amgen Inc. | 031162100 | COM | 38,300 | $11,966,835 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 151,601 | $11,500,452 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 170,147 | $9,218,564 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 440,500 | $9,193,234 | dollars as filed | |
| ALEXANDRIA REAL ESTATE EQ INC COM | 015271109 | REIT | 733 | $8,573,901 | dollars as filed | put |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 1,092 | $8,516,508 | dollars as filed | call |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 332,013 | $8,409,889 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 518,386 | $8,029,799 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 138,262 | $7,329,269 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 276,925 | $7,310,821 | dollars as filed | |
| CARTESIAN THERAPEUTICS INC | 816212302 | COMMON STOCK | 242,370 | $6,546,413 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 1,475,074 | $6,505,077 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 1,860 | $6,043,140 | dollars as filed | call |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 40,000 | $5,506,799 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 1,662,408 | $5,502,571 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 709 | $4,750,300 | dollars as filed | put |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 489,642 | $4,553,672 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 197,096 | $4,243,477 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 107,187 | $4,179,221 | dollars as filed | |
| CERVOMED INC | 15713L109 | COM | 237,345 | $4,063,346 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 903,744 | $3,886,099 | dollars as filed | |
| CYBIN INC | 23256X100 | COM | 13,953,488 | $3,781,396 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 2,789 | $3,628,489 | dollars as filed | put |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 204,513 | $3,536,029 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 506,665 | $3,293,324 | dollars as filed | |
| INHIBRX BIOSCIENCES INC | 45720N103 | COM | 230,000 | $3,259,099 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 768,593 | $3,258,835 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 47,835 | $3,204,945 | dollars as filed | |
| ANNOVIS BIO INC | 03615A108 | COM | 5,517 | $3,177,792 | dollars as filed | put |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 458,497 | $3,122,365 | dollars as filed | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 12,864 | $2,932,992 | dollars as filed | put |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 201,116 | $2,908,138 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 575,088 | $2,869,690 | dollars as filed | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 12,248 | $2,792,544 | dollars as filed | call |
| IMMUNOVANT INC | 45258J102 | COM | 1,000 | $2,640,000 | dollars as filed | call |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 105,175 | $2,387,473 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 323,528 | $2,345,578 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 145,000 | $2,208,350 | dollars as filed | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 4,000 | $2,184,000 | dollars as filed | put |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 4,000 | $2,184,000 | dollars as filed | call |
| Q32 BIO INC | 746964105 | Common Stock | 109,094 | $1,958,237 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 690,089 | $1,863,242 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 380,000 | $1,862,000 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 302,908 | $1,829,564 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 1,312,405 | $1,627,382 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 183,701 | $1,530,229 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 412,565 | $1,410,973 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 108,483 | $1,395,092 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,000 | $1,301,000 | dollars as filed | call |
| IBIO INC | 451033708 | CMN | 600,000 | $1,266,000 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 704,987 | $1,226,677 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 3,586 | $1,186,966 | dollars as filed | call |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 1,443,181 | $1,176,193 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 162,481 | $1,171,487 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 78,574 | $1,166,038 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 290 | $1,138,830 | dollars as filed | put |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 290 | $1,138,830 | dollars as filed | call |
| KODIAK SCIENCES INC | 50015M109 | COM | 476,586 | $1,119,977 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 100,609 | $1,063,437 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 358,282 | $1,046,183 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 62,836 | $1,034,909 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 442,647 | $1,022,514 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 972,675 | $972,675 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 200,079 | $850,337 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 100,370 | $840,097 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 706,154 | $826,200 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 483,583 | $802,748 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 946,382 | $796,191 | dollars as filed | |
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 526,066 | $762,796 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 100,000 | $711,001 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 54,730 | $682,483 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 266,435 | $644,774 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 466,019 | $619,806 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 367,965 | $610,822 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 2,000 | $610,000 | dollars as filed | call |
| IMMATICS N.V | N44445109 | SHS | 49,415 | $574,202 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 493,496 | $547,781 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 274,551 | $521,647 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 868,992 | $521,395 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 154,625 | $471,606 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 55,857 | $441,829 | dollars as filed | |
| ANEBULO PHARMACEUTICALS INC | 034569103 | COM | 157,862 | $430,964 | dollars as filed | |
| SENSEI BIOTHERAPEUTICS INC | 81728A108 | COM | 650,000 | $403,065 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 180,712 | $375,881 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 50,699 | $356,921 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 409,355 | $355,157 | dollars as filed | |
| ANNOVIS BIO INC | 03615A108 | COM | 517 | $297,792 | dollars as filed | call |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 1,056,829 | $292,424 | dollars as filed | |
| AEON BIOPHARMA INC | 00791X100 | CL A | 257,977 | $270,876 | dollars as filed | |
| Tempest Therapeutics, Inc. | 87978U108 | Common Stock | 105,600 | $231,264 | dollars as filed | |
| CHEMOMAB THERAPEUTICS LTD | 16385C104 | SPONSORED ADS | 213,392 | $196,320 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 1,000 | $166,000 | dollars as filed | call |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 40,369 | $121,107 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 6,816 | $92,083 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 171 | $72,504 | dollars as filed | call |
| SYNLOGIC INC | 87166L209 | COM | 20,448 | $30,673 | dollars as filed | |
| BRAINSTORM CELL THERAPEUTICS | 10501E201 | COM | 90,242 | $30,547 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 8,924 | $10,887 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-001556 | this filing | 2024-08-14 | acceptance time not in the bulk data set |